LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
| Q2 2023 | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
| Q1 2023 | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% |
| Q4 2022 | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
| Q3 2022 | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
| Q2 2022 | $13,389,000 | – | 2,369,668 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
| Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
| VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
| Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
| Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
| Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
| Clearline Capital LP | 119,128 | $239,448 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,972 | $20 | 0.00% |